A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis.

Chataway J, Nicholas R, Todd, S, Miller D, Parsons N, Valdés-Márquez E, Stallard N, Friede T (2011). Multiple Sclerosis 17: 81-88.

Follow us